39 / 48
Referências
1. Martits AM, Costa EMF. Late onset male
hypogonadism or andropause. Rev Assoc Med
Bras 2004;50:358-9.
2.
KalacheA,Gender-especific health care in the
21
st
century: a focus on developing countries.
Aging Male 2002;5:129-38.
3.
Lapauw B, Goemaere S, Zmierczak H, Van
Pottelbergh I, Mahmoud A, Taes Y, et al.The
decline of serum testosterone levels in
community-dwelling men over 70 years of
age:descriptivedata and predictors of
longitudinal changes. Eur J Endocrinol
2008;159:459-68.
4.
Sato Y, Kato S, Ohnishi S, Nakajima H,
Nanbu A, Nitta T, et al. Analysis of clinical
manifestation and endocrinological aspects of
patients having PADAM-like symptoms.
Nippon Hinyokika Gakkai Zasshi 2004;95:8-16.
5.
Feldman HA, Longscope C, Derby CA,
Johannes CH, Araujo AB, Coviello Ad, et al.
Age trends in the level of serum testosterone
and other hormones in middle-aged men:
longitudinal results from the Massachusets
Male Aging Study. J Clin Endocrinol Metab
2002;87:589-98.
6.
Schatzl G, Madersbacher S, Temmi C, Krenn-
Scnikel, Nader A, Sregi G, et al. Serum